WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 05-Dec-2014 (Data received as of 1-Dec-2014)
Next overall update June 2015
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 1002
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 1462

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 67'514  65'705  63'932  62'191  60'486  46'949  34'911  26'357 
Births 2'889  2'839  2'790  2'741  2'692  2'255  1'710  1'228 
Surviving infants 2'577  2'529  2'481  2'433  2'386  1'973  1'505  1'072 
Pop. less than 5 years 11'907  11'691  11'455  11'180  10'950  8'844  6'566  4'780 
Pop. less than 15 years 30'400  29'712  29'006  28'275  27'645  21'807  15'894  11'755 
Female 15-49 years 15'488  15'011  14'556  14'125  13'667  10'370  7'857  6'099 

Number of reported case

(Click for retrospective incidence data for Democratic Republic of the Congo (the))
Diphtheria 43 
Japanese encephalitis
Measles 88'381  72'029  133'802  5'407  57  8'282  4'564  32'596 
Mumps
Pertussis 3'407  2'452  2'157  830  75  15'335 
Polio* 17  104  118  603  263 
Rubella 1'704  1'860  318  130  110 
Rubella (CRS)
Tetanus (neonatal) 1'252  888  990  731  77  120 
Tetanus (total) 1'296  943  1'038  1'368  77  848 
Yellow fever 195  289 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Democratic Republic of the Congo (the))
Vaccine year result method % card seen                                                
BCG 2011  89  EPI   35  95  88  77  96  95  57 
DTP1 2011  85  EPI   35  97  99  98  87  99*  49 
DTP3 2011  77  EPI   35  87  89  90  78  92  40 
HepB_BD         
HepB3 2011  77  EPI   35  87  89  90  78  92 
Hib3 2011  77  EPI   35  87  89  90  78  92 
JapEnc         
MCV 2011  74  EPI   35  88  84  85  87  86  46 
MCV2         
PCV1          64  34  18 
PCV3          44  27 
Pol3 2011  81  EPI   35  87  89  90  88  90  42 
Rota1         
Rota_last         
Rubella1         
TT2plus 1994  33  MICS   30  85  86  84  85  83  25 
PAB         
VAD1          99*  99*  85  96 
YFV 2011  71  EPI   35  75  76  63  82  85 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Democratic Republic of the Congo (the))
BCG 78  78  67  86  85  57  65  57 
DTP1 86  86  85  71  82  49  60 
DTP3 72  72  74  60  72  40  35 
HepB3 72  72  74  60  72 
HepB_BD
Hib3 72  72  74  60  72 
MCV 73  73  74  74  72  46  38  18 
MCV2
PAB 75  70  70  77  85  45  53 
PnC3 26  26 
Pol3 76  76  77  76  78  42  34  15 
Rota_last
YFV 61  61  48  67  70 

Number of districts in the country 516  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 55
From 80 to 89% 26
From 50 to 79% 18
Less than 50% 1
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
IPV From March 2015
Measles 9 months; Yes
OPV birth; 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus From January 2016
TT 1st contact pregnancy; +1, +6 months; +1, +1 year; Yes
VitaminA 6, +6 months; Yes every 6 months until 59 months
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2013-2015  2013-2015  2011-2015  2008-2012  2008-2012  2008-2012  2007-2011 
Nº of districts with microplans that include activities to raise immunization coverage number 514  509  235  205  338  508 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No       

System performance

Total Nº districts in country number 516  513  509  508  508  515  515 
Nº districts with DTP3 coverage >=80% number 414  399  353  246  396  278  148 
% of districts with DTP3 coverage >=80% From 0 to 100% 80  78  69  48  78  54  29 
Nº districts with measles (MCV1) coverage >=95% number 137  196  145  147  142  83   
% of districts with MCV1 coverage >=95% From 0 to 100% 27  38  28  29  28  16   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 11 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.